Vetsys Pharmaceutical
Vetsys Pharmaceutical
Top-tier veterinary medications formulated to address acute pathogens and dry cow transitions in sub-Saharan climates.
The agricultural economy of the Central African Republic (CAR) relies heavily on livestock husbandry, particularly in the pastoral zones of Ombella-M'Poko, Lobaye, and the central savannas. While dairy production presents a vital path to dietary security and regional trade, clinical and sub-clinical bovine mastitis acts as a primary threat to herd yields and animal welfare. The lack of domestic animal health pharmaceutical manufacturing makes local operators highly dependent on imports of high-quality intramammary infusions.
High ambient heat, humidity, and pasture-based grazing in Central Africa elevate exposure rates to environmental pathogens such as Escherichia coli and Streptococcus uberis, alongside contagious agents like Staphylococcus aureus. Unmanaged mastitis leads to irreversible mammary tissue damage and substantial financial loss. Delivering stable, temperature-resilient intramammary treatments is critical for veterinary distributors and municipal procurement units throughout the region.
Modern animal pharmaceuticals are moving toward targeted antimicrobial therapy and strict adherence to withdrawal periods. As global initiatives combat antimicrobial resistance (AMR), manufacturers must utilize ultra-precise, localized delivery vehicles, such as intramammary syringes. Advanced polymer tips and non-irritating lipid-based suspensions ensure optimized tissue absorption while safeguarding dairy chain purity.
Vetsys Pharmaceutical stands at the forefront of this evolution, engineering infusions that balance rapid therapeutic action with clean milk output protocols.
A trusted global leader in veterinary science, quality manufacturing, and sustainable animal healthcare.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry. Our state-of-the-art facility features specialized workshops for producing powders, premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in strict compliance with Good Manufacturing Practices (GMP) and ISO quality standards. This rigorous control ensures that all veterinary products, including our highly-regarded intramammary infusions, deliver consistent efficacy under diverse operational conditions. By 2015, the company achieved domestic annual sales exceeding USD 20 million, laying a solid foundation for international expansion and regional support in Africa.
We produce a wide variety of intramammary formulations tailored to combat resistant bacteria and manage tissue healing.
| Active Ingredient Compound | Target Pathogens | Applicable Stage | Key Therapeutic Mechanism |
|---|---|---|---|
| Cefquinome Sulfate (4th Gen Cephalosporin) | S. aureus, E. coli, S. uberis, Klebsiella spp. | Lactating & Dry Cow | Inhibits bacterial cell wall synthesis with high resistance to beta-lactamase degradation. |
| Ampicillin & Cloxacillin (Synergistic Penicillin Mix) | Penicillinase-producing Staphylococci, Streptococci | Dry Cow Therapy | Cloxacillin resists penicillinase destruction while Ampicillin broadens gram-negative coverage. |
| Amoxicillin, Sulbactam & Prednisolone | Beta-lactamase positive environmental pathogens | Lactating Cow (Acute Mastitis) | Sulbactam neutralizes bacterial defenses, Amoxicillin eliminates bacteria, and Prednisolone reduces tissue swelling. |
| Florfenicol | Resistant environmental mastitis strains | Lactating Cow | Inhibits ribosomal protein synthesis, providing bacteriostatic control against tough gram-negative organisms. |
Our GMP-certified manufacturing processes employ precision engineering and cleanroom operations to ensure sterile, stable packaging.
Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for animal health.
Our commitment to research ensures that Vetsys remains at the forefront of the industry, continuously enhancing our product offerings and contributing to advancements in animal healthcare. Our R&D works tirelessly on modern delivery platforms that allow for fast dispersion of active compounds through thick milk fats during lactating stages, and long-acting barriers for dry cow therapy.
Quality is the cornerstone of our operations. Vetsys has developed a comprehensive quality management system to oversee every aspect of production. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions and undergo extensive quality control checks before reaching the market.
Vetsys believes that excellence in product quality is essential to long-term growth and sustainability, both for the company and the animal health industry as a whole. Our focus on quality management allows us to maintain trust and loyalty among our customers, setting us apart as a reliable partner in animal healthcare worldwide.
As part of our long-term vision, Vetsys is also committed to sustainability. We continue to invest in green technologies and environmentally friendly practices to minimize the impact of our operations on the environment. Our products are not only designed for efficacy but also to promote the overall well-being of both animals and the environment.
In addition to our strong presence in the domestic market, Vetsys is actively exploring international expansion, aiming to bring high-quality, innovative animal health solutions to global markets. Our future strategy includes partnerships, research collaborations, and expanding our manufacturing capabilities to meet the increasing demand for safe and effective animal drugs worldwide.
At Vetsys, we are driven by our mission to improve animal health through continuous innovation, world-class quality, and sustainable practices. We remain committed to creating value for our customers, employees, and society as we continue to shape the future of animal healthcare.
Our localized focus for the Central African Republic involves creating targeted logistics partnerships that protect cold chains and ensure consistent distribution of vital veterinary formulations to remote agricultural hubs.
Explore our full range of GMP-certified treatments, offering targeted therapies and combination drugs for optimal farm management.
Implementation methodologies designed to maximize dairy yield and control somatic cell counts in Central African environments.
For active milking cows, treatment must begin immediately upon detection of clinical symptoms (clotted milk, udder swelling). Using targeted infusions like Cefquinome Sulfate for Lactating Cows ensures fast elimination of pathogens. Thoroughly clean the teat end with alcohol wipes before administration to prevent introducing environmental bacteria.
At drying off, administer long-acting formulations like Ampicillin and Cloxacillin Intramammary Infusion. This treatment eliminates subclinical infections contracted during late lactation and creates a protective barrier that persists throughout the dry period, preventing new infections prior to calving.
Given the tropical conditions in CAR, storage integrity is essential. Vetsys uses specially stabilized carrier bases that maintain active ingredient density up to 30°C. Protect the syringes from direct sunlight and keep them in cool, shaded depots during transit and field deployment.
Essential information for veterinary importers, distributors, and farm managers in the Central African Republic.
